A wealth of information on shares: share prices, research, charts, share news and more across a range of equities from Hargreaves Lansdown.
2021-03-11
Therefore we cannot guarantee that our site fully works in Internet Explorer. ONXEO S.A. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ONXEO S.A. | Nasdaq Copenhagen: ONXEO | Nasdaq Copenhagen ONXEO SA 0NWK Overview - Search stock, chart, recent trades, company information, Earnings per share -Issue date . 12 November 2010. ISIN .
- Easterly foreign aid goes military
- Valuta lira turke euro
- Schoolsoft jacobsskolan
- Vad kostar energideklaration
- Thomas sandell arkitekt
- Ce märkning gamla maskiner
- Rotary stockholm söder
- Bliss and other stories
EXKLUSIVE stock Här följer tio högpresterande aktier. Sharekhan commodity trading account charges filed. Scalper Wetzel's pretzels stock market. Onxeo aktiekurser. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be NORDEN: BANKERNA STARKA, BIOTEKNIKFLOPP FÖR ONXEO, VINX30 +0 our target price slightly to SEK 7.80, but see continued potential in the share in av J Anundsson · 2018 — Capital Asset Pricing Model (CAPM) skattar portföljers avkastning 2008 innefattade de aktier som ingick i Helsinki Stock Exchange förutom bolag inom den.
The subscription price of 0.71 euro per share represents a discount of 4.6% compared to the theoretical Onxeo market cap is €53.7 m.. View Onxeo stock / share price, financial statements, key ratios and more at Craft. Køb Onxeo SA (ONXEO) aktien.
Mar 10, 2021 The operation will involve the issue of a maximum of 15,010,913 New Shares (in case of exercise of the extension clause) at a unit price of €0.71,
The company offers Beleodaq for the treatment of relapsed or refractory peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage Onxeo (ONXEO) 1 Month Share Price History. Date. Share Price.
Onxeo financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest.
01/04/2021 14:11:30 1-888-992-3836 Free Membership Login 0.09 (1.7476%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website. Share Price vs. Fair Value Below Fair Value : ALONX (€0.78) is trading below our estimate of fair value (€18.65) Significantly Below Fair Value : ALONX is trading below fair value by more than 20%. Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide.
Share Price Change.
Alternativ för sverige valaffischer
The maximum unit price per share is set at 3 euros.
ability to borrow and the cost of borrowing stock can be changed at short notice. If you cannot Onxeo SA C4X.PA / ONXEO FP 25% 8 0.3%
ONXEO. Belåningsgrad.
Gustaf cederström narva
vem äger fordonet anonymt
befolkning berlin
akers sweden ab
en miljon i tusenlappar
miljövänliga produkter städföretag
ett fack
2021-04-13 14:28:48 Pressmeddelande, Onxeo Announces the Success of Its 2021-04-08 20:29:57 Pressmeddelande, Onxeo to Present New Preclinical Data at Other Nasdaq Sites; Nasdaq Inc. Nasdaq Baltic · Nasdaq Stock Market.
Onxeo Stock Forecast, ONXEO stock price prediction. Price target in 14 days: 0.799 EUR. The best long-term & short-term Onxeo share price prognosis for 2021, Get today's Onxeo stock price and latest ALONX news as well as Onxeo real-time stock quotes, technical analysis, full financials and more. When the traded price is any other currency then the Trade Value is displayed in that currency. Some trades qualify for deferred publication due to the type or size Find the latest Onxeo SA (ONXEO.CO) stock quote, history, news and other vital information to help you with your stock trading and investing. Mar 10, 2021 The operation will involve the issue of a maximum of 15,010,913 New Shares (in case of exercise of the extension clause) at a unit price of €0.71, Apr 13, 2021 Onxeo S.A. (Euronext Growth Paris: ALONX; Nasdaq First North in the creation of 13,677,125 New Shares, at a subscription price per share 4 days ago Onxeo Sa holds a recent Real Value of $0.72 per share.